Pramlintide acetate is a polypeptide analogue of human amylin. Pramlintide acetate, an antidiabetic agent, is antineoplastic in colorectal cancer.
CAT No: HB00109
CAS No:196078-30-5
Chemical Name:(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[(2S)-2-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[(2S)-2-[[(2S,3R)-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]-2-[[(2S,3R)-2-[[(2S)-2-[[(2R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-4-amino-2-[[(2R)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-sulfanylpropanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]-3-sulfanylpropanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]pentanediamide
Pramlintide Acetate is a synthetic analog of the human hormone amylin, developed to mimic the physiological effects of endogenous amylin in metabolic regulation. As a peptide compound, it features a stable structure that allows it to interact effectively with amylin receptors, thereby influencing multiple metabolic pathways. Its design enables it to resist rapid degradation, ensuring that its bioactivity is maintained during experimental applications. Pramlintide Acetate is widely recognized in research settings for its ability to modulate glucose homeostasis and appetite, making it a valuable tool for studies investigating metabolic disorders and energy balance.
Metabolic Research: Pramlintide Acetate is frequently utilized in metabolic research to elucidate the role of amylin in glucose regulation. By administering this peptide in in vitro and in vivo models, researchers can observe its effects on insulin secretion, glucagon suppression, and gastric emptying rates. These studies contribute to a deeper understanding of the hormonal interplay involved in maintaining blood glucose levels, particularly in the context of metabolic syndrome and related disorders. The ability of Pramlintide Acetate to modulate these pathways makes it an essential reagent for dissecting the complex mechanisms of energy homeostasis.
Obesity and Appetite Regulation: In the field of obesity research, Pramlintide serves as a critical tool for investigating the neural and hormonal controls of appetite. Its action on the central nervous system, particularly in reducing food intake and promoting satiety, provides insights into the pathways that contribute to overeating and weight gain. By incorporating this compound into experimental protocols, scientists can explore the downstream effects of amylin signaling on appetite-regulating neurons and identify potential targets for intervention in obesity and related metabolic disorders.
Peptide Drug Development: Pramlintide Acetate's structure and pharmacological profile offer a valuable template for the development of next-generation peptide therapeutics. Researchers interested in designing novel amylin receptor agonists or analogs often use this compound as a reference standard. Comparative studies involving Pramlintide Acetate allow for the assessment of structural modifications and their impact on activity, stability, and receptor selectivity. The insights gained from these investigations facilitate the rational design of improved peptide drugs for metabolic research applications.
Endocrine Function Studies: Scientists exploring the broader aspects of endocrine function utilize Pramlintide in experimental models to assess its influence on hormone secretion and pancreatic islet biology. Its ability to modulate the secretion of insulin and glucagon, as well as its interactions with other islet hormones, provides a unique perspective on islet cell communication and function. These studies are instrumental in advancing the understanding of islet physiology and the hormonal dysregulation associated with metabolic diseases.
Gastrointestinal Motility Research: Another key application of Pramlintide Acetate is in the study of gastrointestinal motility. By slowing gastric emptying, this peptide allows researchers to investigate the relationship between gut transit times, nutrient absorption, and postprandial glucose excursions. Such research is critical for identifying the physiological mechanisms that link gastrointestinal function with metabolic control. The use of Pramlintide Acetate in these studies supports the development of novel strategies for managing metabolic disturbances through modulation of gut motility.
Collectively, Pramlintide Acetate stands out as a multifaceted research tool in the investigation of metabolic regulation, appetite control, peptide drug development, endocrine function, and gastrointestinal motility. Its unique properties and well-characterized mechanism of action have enabled significant advances in our understanding of amylin biology and its implications for metabolic health. By supporting a wide range of experimental approaches, Pramlintide Acetate continues to drive innovation in the study of metabolic and endocrine systems, offering researchers a reliable and versatile compound for their scientific endeavors.
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.